WebEscalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT WebApr 4, 2024 · Regardless of lines of therapy, the treatment with ICIs had the most favorable outcome with a median PFS and OS of 3.98 and NR years, respectively. Allogeneic stem cell transplant (allo-SCT) was done in 23 patients (20%), and the median post-allo-SCT PFS and OS were 1.31 and 2.35 years, respectively.
Leukemic Dendritic Cell Vaccination in Patients With Acute …
WebFeb 5, 2024 · Europe PMC is an archive of life sciences journal literature. WebAug 29, 2024 · In recent years, the relevance of the immune system to fight cancer has led to the development of immunotherapy, including the adoptive cell transfer of immune cells, such as natural killer (NK) cells and chimeric antigen receptors (CAR)-modified T cells. The discovery of donor NK cells’ anti-tumor activity in acute myeloid leukemia patients … hearth and hand backpack
Tyrosine Kinase Inhibitors Dasatinib, Nilotinib and Imatinib Have …
WebNov 16, 2007 · Although autologous transplant remains standard of care for patients with multiple myeloma, it is rarely curative. Allogeneic peripheral stem cell tra… WebTransplant-associated thrombotic microangiopathy (TMA) occurs in a significant percentage of patients after allogeneic stem cell transplantation (allo-SCT) and is associated with significant morbidity and mortality. The aim of the present study was to examine the association of serum angiopoetin-2 (Ang2) levels and the presence of antibodies against … WebDec 12, 2012 · Problem-solving card text (PSCT) has put more information at your fingertips, right on the cards where it belongs. But PSCT is an evolving beast. We’ve incorporated more improvements over the last year, and will be rolling out some more in … mounted pressure switch